Chloroquine is thought to exert its antimalarial effect by preventing the polymerization of toxic heme released during proteolysis of hemoglobin in the Plasmodium digestive vacuole. 
The quinolines have been used as specific antimalarial therapy for more than 300 years, yet their mechanisms of action have been difficult to establish (1) . In the acidic digestive vacuole, proteolysis of hemoglobin (2) releases toxic heme that is polymerized only in plasmodial species into an inert crystal called malarial pigment or hemozoin (3, 4) . Heme polymerization is an elongation reaction with evidence for nucleation by histidine-rich proteins (HRPs) (5) . Lipids may also play a role (6) . Preformed hemozoin chains can also be extended in the absence of proteins (7, 8) . Multiple lines of evidence indicate that quinolines such as chloroquine, mefloquine, quinine, and quinidine act by inhibiting polymerization of the heme that is released during hemoglobin degradation. (i) In vitro these quinolines block the polymerization of micromolar heme into hemozoin under approximated physiological conditions mediated by crude trophozoite lysates (9) , seed crystals of hemozoin (7), or isolated Plasmodium falciparum-derived HRPs (5) . Chemical polymerization of heme under nonphysiological conditions is similarly inhibited (8) 
(ii) The quinoline inhibition is stage-specific for parasites actively degrading hemoglobin and generating hemozoin (1) . (iii) Early morphologic effects of drug treatment are digestive vacuolar swelling (10) and pigment clumping (11) . (iv) Chloroquine and its congeners hyperconcentrate to near millimolar concentration in the acidic digestive vacuole of P. falciparum from nanomolar concentration in the plasma (12, 13) .
It has been postulated that the chloroquine-induced disruption of heme polymerization results either from binding of drug to heme with sequestration of monomeric substrate or from direct interaction of chloroquine with a polymerization protein. Chloroquine and its congeners bind heme noncovalently (14, 15) ; ring-ring stacking of the quinoline nucleus with the porphyrin moiety is observed by NMR (16) . Photoacoustic spectrophotometry has detected chloroquine-heme complexes in situ (17) , although they have never been isolated from the parasite. Arguments against substrate-drug interaction lowering available substrate are that quinine, quinidine, and epiquinine interact equally with heme, yet vary 100-fold in their ability to inhibit in vitro heme polymerization (1) . Likewise chloroquine has a higher heme avidity than quinidine or quinine yet is a weaker inhibitor of in vitro heme polymerization (1) . Also mefloquine, quinine, and quinidine inhibit in vitro polymerization in the presence of 7-to 20-fold excess heme (1) . On the other hand, an argument against direct drug interaction with a polymerization protein is that chloroquine blocks the hemozoin-elongation reaction in the absence of protein (7, 8) .
In the current study, we have examined the association of (19) . The early trophozoite cultures in 15-ml plates were incubated for [20] [21] [22] [23] [24] (Fig. 1A) . Statistical analysis of the signal distribution (500 cells) revealed that the infected erythrocytes were 23.4 times more likely to have signal than uninfected erythrocytes. Within infected erythrocytes, signal was strongly associated with hemozoin (Fig. 1B) .
For further analysis, similar parasite cultures (chloroquinesensitive clone HB3) incubated with [3H]chloroquine or quinidine were disrupted by sonication in hypotonic buffer. The extracts were purified by centrifugation through a 1.7 M sucrose cushion, with hemozoin pelleting to the bottom. Western blot analysis confirmed separation of hemozoin from >99% of membrane and soluble protein markers (data not shown). The hemozoin pellet contained 35-70% of the parasite-associated [3H]quinoline (Fig. 2) . Nearly all the radioactivity sedimentable without sucrose was hemozoin-associated by sucrose cushion analysis. Hemozoin recovery in the sucrose cushion pellet was 75% (12 nmol). Control parasite lysates mixed with [3H]quinoline and incubated for 15 0Q Q+HRP+Heme 04HRP Q+Heme Q Proc. Natl. Acad. Sci. USA 93 (1996) [3H]quinoline association with hemozoin. This rules out nonspecific binding during lysis as a possibility. Heme-quinoline complexes also did not pellet in this procedure. Using the chloroquine-resistant Indochinal/CDC strain, which is believed to have reduced drug accumulation due to increased efflux (26) , [3H]chloroquine in parasite lysates was reduced and hemozoin-associated radioactivity was minimal ( Fig. 2A) . In contrast, [3H]quinidine accumulation and incorporation into the hemozoin pellet were comparable to the HB3 results (Fig. 2B) , consistent with Indochina 1 /CDC being a quinidinesensitive strain.
In Vitro [3H] Quinolines Interact With Hemozoin. Hemozoin formation can be nucleated in the test tube with preformed hemozoin (7) or with HRP II and III, which can be found in the parasite digestive vacuole (5).
[3H]Chloroquine (4 nM) was incubated with heme (50 ,uM) and purified malarial hemozoin overnight. The reaction mixture was placed on a 1.7 M sucrose cushion and ultracentrifuged as above. Substantial [3H]chloroquine was found in the hemozoin pellet (Fig. 3A). [3H]Chloroquine incubated with hemozoin in the absence of heme did not pellet; nor did [3H]chloroquine incubated with heme without hemozoin as template.
[3H]Quinidine behaved similarly in these assays (Fig. 3B) . A time course demonstrates increasing [3H]quinoline incorporation with increasing hemozoin synthesis (Fig. 3 C and D) . Hemozoin yield was similiar with and without [31H]quinoline.
Initiating the reaction with recombinant HRP II instead of hemozoin also led to incorporation of radioactivity into the polymer pellet using [3H]chloroquine (Fig. 4A) or [3H]quinidine (Fig. 4B) . Coincubation of HRP II with 3H-labeled drug in the absence of heme gave no sedimentable radioactivity. The interaction of HRP II with chloroquine in the absence of heme was further explored under equilibrium conditions and no association could be detected. Labeled chloroquine concentration did not differ significantly between the retentates and filtrates in multiple determinations (data not shown).
Interestingly, in the presence of heme, chloroquine incorporation was higher than quinidine incorporation, in contrast to the whole cell results (Fig. 2) and the hemozoin-initiated synthesis (Fig. 3) . To explore this, purified HRP II-produced hemozoin was further incubated with fresh heme in the presence of 3H-labeled drug (Fig. 4 C and D) . Quinidine incorporation was greater than chloroquine incorporation (600% greater than quinidine incorporation for HRP IIinitiated production), suggesting that drug-heme complexes have differing affinities for the initiating chain than for the extending polymer. Starting with purified HRP II-produced hemozoin, new hemozoin synthesis was similiar to that of Fig.  3 and was minimally (40%) higher than the HRP IT-initiated synthesis of Fig. 4 A and implicates the drug-heme complex in capping the hemozoin to block polymer extension (Fig. 5) 
